www.fdanews.com/articles/183495-fda-to-pilot-new-high-risk-pma-for-medical-devices
![FDA_Logo_Black_2016.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/FDA_Logo_Black_2016.gif?t=1579040596&width=430)
FDA to Pilot New High-Risk PMA for Medical Devices
September 13, 2017
The FDA is preparing a pilot program to improve the pre-market approval process for high-risk medical devices.
The agency is seeking nine companies to participate in its Premarket Approval Application Critical to Quality program. The goal is to streamline the PMA process to assure a firm’s quality system includes rigorous controls for features and characteristics considered critical to the safety and effectiveness of the device.
Rather than undergo pre-approval inspections, participants in the PMA CtQ program would agree to post-approval inspections focused on design, manufacturing and quality assurance criteria developed in collaboration with the FDA.